5.70
8.80%
-0.55
Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten
Oppenheimer Reiterates "Outperform" Rating for ESSA Pharma (NASDAQ:EPIX) - MarketBeat
MarketBeat
(EPIX) Trading Signals - Stock Traders Daily
Stock Traders Daily
ESSA Pharma Inc. (NASDAQ:EPIX) Sees Large Growth in Short Interest - MarketBeat
MarketBeat
ESSA Pharma: Fiscal Q2 Earnings Snapshot - Darien Times
Darien Times
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31 ... - br.ADVFN.com
br.ADVFN.com
ESSA Pharma: Fiscal Q2 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Boyd Gaming Co. (NYSE:BYD) Short Interest Up 20.4% in April - Defense World
Defense World
Deal Watch: Parvus Signs Second Big Pharma Alliance, With Genentech - Scrip
Scrip
ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below Fifty Day Moving Average of $7.91 - MarketBeat
MarketBeat
ESSA Pharma (NASDAQ:EPIX) Stock Passes Below Fifty Day Moving Average of $7.91 - Defense World
Defense World
2500 Shares in Biomea Fusion, Inc. (NASDAQ:BMEA) Acquired by Signaturefd LLC - Defense World
Defense World
Hedge funds investors in ESSA Pharma Inc. (NASDAQ:EPIX) lost 12% last week but have reaped the benefits of longer-term growth - Simply Wall St
Simply Wall St
PBYI Stock Quote Price and Forecast - CNN
CNN
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business - Yahoo Finance
Yahoo Finance
Exclusive: Norway's wealth fund pushes for more women on emerging market company boards - Reuters.com
Reuters.com
ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results - Yahoo Finance
Yahoo Finance
ESSA Pharma: Fiscal Q1 Earnings Snapshot - Quartz
Quartz
ESSA Pharma Inc Executive Peter Virsik Sells 72,782 Shares - Yahoo Finance
Yahoo Finance
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
Benzinga
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday - Markets Insider
Markets Insider
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term ... - Yahoo Finance
Yahoo Finance
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Benzinga
Applied Digital, ESSA Pharma And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session By Benzinga - Investing.com UK
Investing.com UK
Metastatic Castration-Resistant Prostate Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 7.5 ... - PR Newswire
PR Newswire
Metastatic Prostate Cancer Market to Exhibit Positive Growth at a CAGR of 22% and 7.5% for mHSPC and mCRPC ... - PR Newswire
PR Newswire
ESSA Pharma Inc (EPIX) Reports Fiscal Q4 and Full-Year Earnings, Advances in Prostate Cancer ... - Yahoo Finance
Yahoo Finance
EPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat… - Yahoo Finance
Yahoo Finance
EPIX: Phase 2 Trial of EPI-7386 in Combination with Enzalutamide to Initiate in Calendar 3Q23… - Yahoo Finance
Yahoo Finance
EPIX: Moving Towards Phase 2 Trial of EPI-7386 in Combination with Enzalutamide… - Yahoo Finance
Yahoo Finance
EPIX: Deep and Sustained PSA Responses in Phase 1/2 Combination Trial of EPI-7386 and Enzalutamide… - Yahoo Finance
Yahoo Finance
DelveInsight Evaluates a Robust Prostate Cancer Pipeline as 170+ Influential Pharma Players to Set Foot in the Domain - PR Newswire
PR Newswire
Cotações de Ações Americanas: Bolsas ao vivo e últimas notícias - Money Times
Money Times
Essa Pharma discloses new androgen receptor antagonists - BioWorld Online
BioWorld Online
EPIX: Promising Early Data for EPI-7386 in Combination with Enzalutamide… - Yahoo Finance
Yahoo Finance
Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues - BioSpace
BioSpace
StockWatch: Astellas Hones Gene Therapy Focus with Taysha Stake - Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Franklin M Berger Net Worth (2024) - GuruFocus.com
GuruFocus.com
Centessa still finding itself as it cuts another program - The Pharma Letter
The Pharma Letter
EPIX: Multiple Ongoing Studies of EPI-7386… - Yahoo Finance
Yahoo Finance
BioSpace Movers & Shakers: National Cancer Institute, Evelo, Eagle, ROME & More - BioSpace
BioSpace
Evelo Biosciences Appoints Marella Thorell as Chief Financial Officer - citybiz
citybiz
Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswire
GlobeNewswire
EPIX: Clinical Update on Phase 1 Monotherapy Trial of EPI-7386 Expected in 2Q22… - Yahoo Finance
Yahoo Finance
EPIX: First Patient Dosed in Combination Trial of EPI-7386 and Enzalutamide… - Yahoo Finance
Yahoo Finance
ESSA Pharma Stock: Why I Remain Bullish (NASDAQ:EPIX) - Seeking Alpha
Seeking Alpha
Caris Life Sciences and ESSA Pharma Announce Liquid Biopsy Profiling Collaboration - PR Newswire
PR Newswire
Novel NTD Inhibitor EPI-7386 Plus Enzalutamide Under Evaluation in mCRPC - OncLive
OncLive
Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies - GlobeNewswire
GlobeNewswire
Medicxi launches asset-centric Centessa by acquiring 10 companies - BioWorld Online
BioWorld Online
Kapitalisierung:
|
Volumen (24h):